FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, more specifically to new methods and materials for removal of undesired types of nucleic acids (in particular, RNA) from a sample of target nucleic acid.
EFFECT: invention discloses a sequence of actions for effective removal from a nucleic acid preparation of undesired rRNA, tRNA, mRNA, or other types, which can prevent analysis, manipulation, and study of target RNA molecules in a sample.
49 cl, 8 ex, 3 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NUCLEIC ACID MOLECULES FOR REDUCING THE LEVEL OF PAPD5 OR PAPD7 MRNA FOR TREATING INFECTIOUS HEPATITIS B | 2017 |
|
RU2768699C2 |
| COMPOSITIONS BASED ON STABILIZED FIBRONECTIN DOMAINS, METHODS AND APPLICATIONS THEREOF | 2011 |
|
RU2767543C2 |
| COMPOSITIONS AND METHODS FOR IMMUNE ONCOLOGY | 2016 |
|
RU2771624C2 |
| NEW FISH CORONAVIRUS | 2020 |
|
RU2813731C2 |
| COMPOUND FOR MODULATION OF C9ORF72 GENE EXPRESSION AND USE THEREOF | 2013 |
|
RU2730677C2 |
| TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA | 2015 |
|
RU2751660C2 |
| ANTIBODY AGAINST MALIGNANT CELL, ANTI-CANCER DRUG AND METHOD FOR TESTING MALIGNANT NEOPLASM | 2015 |
|
RU2753512C2 |
| ILT7 BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2756109C2 |
| NEW FISH TOTIVIRUS | 2020 |
|
RU2798051C2 |
| CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF | 2014 |
|
RU2714902C2 |
